Choleretic activity

Choleretic activity refers to the biological process or pharmacological effect of stimulating the liver to increase the production and secretion of bile. It is not a singular molecular target such as a protein or receptor, but rather a physiological outcome mediated by various hepatocyte transporters and regulatory pathways (NIH/StatPearls). This activity is crucial for the digestion and absorption of dietary lipids and fat-soluble vitamins, as well as the elimination of endogenous waste products and xenobiotics. In a clinical context, substances with choleretic activity are utilized to manage cholestatic liver diseases, where bile flow is impaired, and to assist in the dissolution of certain types of gallstones (PubMed/PubChem). Drugs that induce this activity, such as ursodeoxycholic acid, often act by modulating nuclear receptors like the Farnesoid X Receptor (FXR) or by increasing the expression of biliary export pumps like the Bile Salt Export Pump (BSEP/ABCB11). Increased bile flow helps to 'flush' the biliary tree, reducing the concentration of toxic hydrophobic bile acids and preventing lithogenesis. However, because it describes a functional effect rather than a specific molecule, 'Choleretic activity' is classified as a therapeutic class or biological property rather than a target in drug discovery databases.

Other names

Bile flow stimulationBiliary secretion stimulationHydrocholeretic effectCholeretic effect

Stimulation of hepatocytes to increase the volume of bile secretion, either through bile acid-dependent mechanisms (increasing bile salt excretion) or bile acid-independent mechanisms (increasing water and electrolyte secretion via transporters like MRP2 or cystic fibrosis transmembrane conductance regulator).